(3-Methyl-4-(piperidin-1-ylsulfonyl)phenyl)boronic acid, 97%, 1g

Dinaphtho[2,1-b:1',2'-d]furan, 97%, 5g

4-Methylsulfonyl-3-(pyrrolidin-1-yl)benzoic acid, 95.0%, 1g

Dimethyl D-(+)-Malate>98.0%(GC)5g

2-[2-Fluoro-5-(trifluoromethyl)phenyl]ethanol, 5g

2,6-Diisopropylbenzoic acid, 250mg

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)benzaldehyde, 95%, 1g

1-TERT-BUTYL-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE, 95%, 100mg

Anti-GM1 Monoclonal Antibody1vial

(2R,6S)-4-(tert-Butoxycarbonyl)-6-(hydroxymethyl)morpholine-2-carboxylic acid, 98%, 250mg

1-(4-Chloro-3-methylphenyl)ethanol, 97.0%, 100mg

tert-Butyl (R)-2-cyanomorpholine-4-carboxylate, 95%, 100mg

5,7-Dichloro-indole-2-carboxylic acid, 95.0%, 10g